Does perverse economic incentive lead to the irrational uses of medicines

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 13, Issue 6, 2013, Pages 693-696

  Mao, Wenhui ^a   Tang, Shenglan ^b   Chen, Wen ^a  

^a FUDAN UNIVERSITY   (China)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

economic incentives; essential medicine policy; irrational use of medicines; pre payment; profit seeking behavior; zero mark up policy

Indexed keywords

ANTIINFECTIVE AGENT; PRESCRIPTION DRUG;

DRUG MARKETING; DRUG USE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH HAZARD; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; PATIENT ATTITUDE; PERFORMANCE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PROTOCOL COMPLIANCE; PUBLIC HEALTH; REVIEW; SELF MEDICATION;

HUMANS; INAPPROPRIATE PRESCRIBING; MOTIVATION; PHYSICIAN INCENTIVE PLANS; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; REIMBURSEMENT, INCENTIVE;

EID: 84887926387     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2013.856266     Document Type: Review

References (10)

1. Dong L, Yan H, Wang D. Antibiotic prescribing patterns in village health clinics across 10 provinces of western China. J. Antimicrob. Chemother. 62(2), 410-415 (2008).
2. Liu L, Lu Z, Zhang X. Analysis of Rational use of Drugs in Community Health Service Facilities. Chinese Health Econ. 28(4), 45-47 (2009).
3. Liang X, Jin C, Wang L et al. Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China. Int. J. Clin. Pharm. 33(5), 750-754 (2011).
4. Zhang Z, Zhen J, Zhan S et al. Adverse drug reaction and rational use of levofloxacin: A prospective study. Chin. J. Epidemiol. 22(6), 405-407 (2001).
5. Dong L, Yan H, Wang D. Polypharmacy and its correlates in village health clinics across 10 provinces of western China. J. Epidemiol. Community Health 64(6), 549-553 (2009)
6. Chen W, Tang S, Sun J, Ross-Degnan D, Wagner A. Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces. BMC Health Serv. Res. 10, 211 (2010).
7. China National Health Economics Institute. China national health accounts report 2009. Ministry of Health, Beijing, China (2009).
8. Wu A, Li C, Wen X, Ren N. National Healthcare-associated infection surveillance system point-prevalence survey of antimicrobial use in 740 Chinese hospitals in 2010. Chin. J. Infect. Control. 11(1), 7-11 (2012).
9. Reynolds L, McKee M. Serve the people or close the sale Profit-driven overuse of injections and infusions in China's market-based healthcare system. Int. J. Health Plann. Mgmt 26, 449-470 (2011).
10. Dong H, Bogg L, Rehnberg C, Diwan V. Health financing policies: Providers' opinions and prescribing behavior in rural China. Int. J. Technol. Assessm. Health Cares 15(4), 686-698 (1999).